Arguedas A, Loaiza C, Perez A, Vargas F, Herrera M, Rodriguez G, Gutierrez A, Mohs E
National Children's Hospital, Universidad Autonoma de Ciencias Medicas, San Jose, Costa Rica.
Pediatr Infect Dis J. 1998 Aug;17(8):680-9. doi: 10.1097/00006454-199808000-00004.
Because of the increasing number of resistant middle ear pathogens reported from different centers worldwide, an active surveillance of the microbiology and susceptibility pattern of middle ear pathogens is required for proper antimicrobial recommendations among different regions of the world.
To study the microbiology and susceptibility pattern of middle ear pathogens obtained from Costa Rican children with acute otitis media.
Between 1992 and 1997 a diagnostic tympanocentesis was performed in 398 Costa Rican patients with acute otitis media. Middle ear fluid was obtained for culture and minimal inhibitory concentrations were determined by the E-test technique in those isolates obtained between October, 1995, and January, 1997.
The most common pathogens cultured were Streptococcus pneumoniae (30%), Haemophilus influenzae (14%), Staphylococcus aureus (4%) and Streptococcus pyogenes (4%). Moraxella catarrhalis was uncommon. Beta-lactamase production was low (3.7%) among the H. influenzae isolates but frequent among the Staphylococcus aureus (57.1%) and M. catarrhalis (100%) strains. Overall 9 of 46 S. pneumoniae isolates (19.6%) exhibited decreased susceptibility to penicillin of which 8 isolates (17.4%) showed intermediate and one strain (2.2%) high level resistance. Among the penicillin-susceptible S. pneumoniae isolates, susceptibility to the following antimicrobials was: 81%, azithromycin; 89%, clarithromycin; and 100%, ceftriaxone and trimethoprim-sulfamethoxazole (TMP-SMX). Among the penicillin-resistant S. pneumoniae isolates the percentage of susceptible strains was 89% for azithromycin, clarithromycin and ceftriaxone and 67% for TMP-SMX.
Based on this microbiologic information the agents considered first line drugs in the treatment of acute otitis media in Costa Rica remain amoxicillin or TMP-SMX.
由于世界各地不同中心报告的中耳耐药病原体数量不断增加,因此需要对中耳病原体的微生物学和药敏模式进行积极监测,以便在世界不同地区给出适当的抗菌药物推荐。
研究从患有急性中耳炎的哥斯达黎加儿童中分离出的中耳病原体的微生物学和药敏模式。
1992年至1997年间,对398例患有急性中耳炎的哥斯达黎加患者进行了诊断性鼓膜穿刺术。获取中耳积液进行培养,并对1995年10月至1997年1月间分离出的菌株采用E-test技术测定最低抑菌浓度。
培养出的最常见病原体为肺炎链球菌(30%)、流感嗜血杆菌(14%)、金黄色葡萄球菌(4%)和化脓性链球菌(4%)。卡他莫拉菌不常见。流感嗜血杆菌分离株中β-内酰胺酶的产生率较低(3.7%),但在金黄色葡萄球菌(57.1%)和卡他莫拉菌(100%)菌株中较为常见。总体而言,46株肺炎链球菌分离株中有9株(19.6%)对青霉素的敏感性降低,其中8株(17.4%)表现为中介耐药,1株(2.2%)表现为高水平耐药。在对青霉素敏感的肺炎链球菌分离株中,对以下抗菌药物的敏感性为:阿奇霉素81%;克拉霉素89%;头孢曲松和复方磺胺甲恶唑(TMP-SMX)均为100%。在对青霉素耐药的肺炎链球菌分离株中,对阿奇霉素、克拉霉素和头孢曲松敏感的菌株百分比为89%,对TMP-SMX敏感的菌株百分比为67%。
基于这些微生物学信息,在哥斯达黎加,治疗急性中耳炎的一线药物仍为阿莫西林或TMP-SMX。